These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 18983139)

  • 21. Pharmacological characterization of A-960656, a histamine H₃ receptor antagonist with efficacy in animal models of osteoarthritis and neuropathic pain.
    Cowart M; Hsieh G; Black LA; Zhan C; Gomez EJ; Pai M; Strakhova M; Manelli A; Carr T; Wetter J; Lee A; Diaz G; Garrison T; Brioni JD
    Eur J Pharmacol; 2012 Jun; 684(1-3):87-94. PubMed ID: 22504024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and evaluation of 4-amino-3,4-dihydro-2H-naphthalen-1-one derivatives as mast cell stabilising and anti-inflammatory compounds.
    Barlow JW; Walsh JJ
    Eur J Med Chem; 2008 Dec; 43(12):2891-900. PubMed ID: 18406013
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonists.
    Venable JD; Cai H; Chai W; Dvorak CA; Grice CA; Jablonowski JA; Shah CR; Kwok AK; Ly KS; Pio B; Wei J; Desai PJ; Jiang W; Nguyen S; Ling P; Wilson SJ; Dunford PJ; Thurmond RL; Lovenberg TW; Karlsson L; Carruthers NI; Edwards JP
    J Med Chem; 2005 Dec; 48(26):8289-98. PubMed ID: 16366610
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis, in vitro, and in vivo biological evaluation and molecular docking simulations of chiral alcohol and ether derivatives of the 1,5-diarylpyrrole scaffold as novel anti-inflammatory and analgesic agents.
    Biava M; Porretta GC; Poce G; Supino S; Manetti F; Forli S; Botta M; Sautebin L; Rossi A; Pergola C; Ghelardini C; Norcini M; Makovec F; Giordani A; Anzellotti P; Cirilli R; Ferretti R; Gallinella B; La Torre F; Anzini M; Patrignani P
    Bioorg Med Chem; 2008 Sep; 16(17):8072-81. PubMed ID: 18752957
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterization of the histamine H4 receptor binding site. Part 1. Synthesis and pharmacological evaluation of dibenzodiazepine derivatives.
    Smits RA; Lim HD; Stegink B; Bakker RA; de Esch IJ; Leurs R
    J Med Chem; 2006 Jul; 49(15):4512-6. PubMed ID: 16854056
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Synthesis of new 5,6-dihydrobenzo[h]quinazoline 2,4-diamino substituted and antiplatelet/antiphlogistic activities evaluation.
    Brullo C; Rocca M; Fossa P; Cichero E; Barocelli E; Ballabeni V; Flammini L; Giorgio C; Saccani F; Domenichini G; Bruno O
    Bioorg Med Chem Lett; 2012 Jan; 22(2):1125-9. PubMed ID: 22189137
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Divergent peripheral effects of pituitary adenylate cyclase-activating polypeptide-38 on nociception in rats and mice.
    Sándor K; Bölcskei K; McDougall JJ; Schuelert N; Reglodi D; Elekes K; Petho G; Pintér E; Szolcsányi J; Helyes Z
    Pain; 2009 Jan; 141(1-2):143-50. PubMed ID: 19091468
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel vanilloid receptor-1 antagonists: 3. The identification of a second-generation clinical candidate with improved physicochemical and pharmacokinetic properties.
    Wang HL; Katon J; Balan C; Bannon AW; Bernard C; Doherty EM; Dominguez C; Gavva NR; Gore V; Ma V; Nishimura N; Surapaneni S; Tang P; Tamir R; Thiel O; Treanor JJ; Norman MH
    J Med Chem; 2007 Jul; 50(15):3528-39. PubMed ID: 17585751
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Discovery of novel analgesic and anti-inflammatory 3-arylamine-imidazo[1,2-a]pyridine symbiotic prototypes.
    Lacerda RB; de Lima CK; da Silva LL; Romeiro NC; Miranda AL; Barreiro EJ; Fraga CA
    Bioorg Med Chem; 2009 Jan; 17(1):74-84. PubMed ID: 19059783
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential modulation of inflammatory pain by a selective estrogen receptor beta agonist.
    Gardell LR; Hyldtoft L; Del Tredici AL; Andersen CB; Fairbairn LC; Lund BW; Gustafsson M; Brann MR; Olsson R; Piu F
    Eur J Pharmacol; 2008 Sep; 592(1-3):158-9. PubMed ID: 18644363
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and structure-activity relationships of indole and benzimidazole piperazines as histamine H(4) receptor antagonists.
    Terzioglu N; van Rijn RM; Bakker RA; De Esch IJ; Leurs R
    Bioorg Med Chem Lett; 2004 Nov; 14(21):5251-6. PubMed ID: 15454206
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis of some new quinazolines and quinoxalines of potential antiinflammatory activity.
    el-Bendary ER; el-Ashmawy MB; Barghash AM; Shehata IA; el-Kerdawy MM
    Boll Chim Farm; 1996 Dec; 135(11):617-20. PubMed ID: 9066171
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, anticonvulsant, and anti-inflammatory evaluation of some new benzotriazole and benzofuran-based heterocycles.
    Dawood KM; Abdel-Gawad H; Rageb EA; Ellithey M; Mohamed HA
    Bioorg Med Chem; 2006 Jun; 14(11):3672-80. PubMed ID: 16464601
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Additive anti-hyperalgesia of electroacupuncture and intrathecal antisense oligodeoxynucleotide to interleukin-1 receptor type I on carrageenan-induced inflammatory pain in rats.
    Song MJ; Wang YQ; Wu GC
    Brain Res Bull; 2009 Mar; 78(6):335-41. PubMed ID: 19022353
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel transient receptor potential vanilloid 1 receptor antagonists for the treatment of pain: structure-activity relationships for ureas with quinoline, isoquinoline, quinazoline, phthalazine, quinoxaline, and cinnoline moieties.
    Gomtsyan A; Bayburt EK; Schmidt RG; Zheng GZ; Perner RJ; Didomenico S; Koenig JR; Turner S; Jinkerson T; Drizin I; Hannick SM; Macri BS; McDonald HA; Honore P; Wismer CT; Marsh KC; Wetter J; Stewart KD; Oie T; Jarvis MF; Surowy CS; Faltynek CR; Lee CH
    J Med Chem; 2005 Feb; 48(3):744-52. PubMed ID: 15689158
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-based design of potent retinoid X receptor alpha agonists.
    Haffner CD; Lenhard JM; Miller AB; McDougald DL; Dwornik K; Ittoop OR; Gampe RT; Xu HE; Blanchard S; Montana VG; Consler TG; Bledsoe RK; Ayscue A; Croom D
    J Med Chem; 2004 Apr; 47(8):2010-29. PubMed ID: 15056000
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Aryl-1,3,5-triazine derivatives as histamine H4 receptor ligands.
    Łażewska D; Więcek M; Ner J; Kamińska K; Kottke T; Schwed JS; Zygmunt M; Karcz T; Olejarz A; Kuder K; Latacz G; Grosicki M; Sapa J; Karolak-Wojciechowska J; Stark H; Kieć-Kononowicz K
    Eur J Med Chem; 2014 Aug; 83():534-46. PubMed ID: 24996140
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Major advances in the development of histamine H4 receptor ligands.
    Smits RA; Leurs R; de Esch IJ
    Drug Discov Today; 2009 Aug; 14(15-16):745-53. PubMed ID: 19477292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent and orally bioavailable CCR4 antagonists: Synthesis and structure-activity relationship study of 2-aminoquinazolines.
    Yokoyama K; Ishikawa N; Igarashi S; Kawano N; Masuda N; Hamaguchi W; Yamasaki S; Koganemaru Y; Hattori K; Miyazaki T; Ogino S; Matsumoto Y; Takeuchi M; Ohta M
    Bioorg Med Chem; 2009 Jan; 17(1):64-73. PubMed ID: 19081254
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.